New challenges will test Pokemon trainers' reactions in their virtual beast battles, as the near-30-year-old saga's latest installment hits Nintendo consoles on Thursday. "Pokemon Legends: Z-A" will ...

Kush Maini will continue as Mahindra Racing's official reserve driver for Formula E Season 12, extending his two-year tenure with the team. He will support race drivers Nyck de Vries and Edoardo ...

Botensilimab (Fc-enhanced anti–cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti–PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas ASCO Guidelines ...

Formula 1 announced a five-year deal Friday with Apple, which will be the global motorsports series' U.S. broadcast partner beginning next season. ESPN had been the broadcast partner since 2018 and ...

Christian Horner is in talks with Ferrari about taking over as their team principal, Daily Mail Sport can reveal. The former Red Bull boss left his job at the Milton Keynes-based team with an ...

A TEEN prison officer has appeared in court over an alleged cell romp with an inmate. Alicia Novas, 19, is accused of entering a relationship with tattooed lag Declan Winkless while working at Five ...

Talking about the match, left-handed Tony de Zorzi showed a lot of composure against the spinners on an abrasive wicket and was unbeaten on a skillful 81 by stumps on day two, but South Africa still ...

The New York Stem Cell Foundation, a $23-million-a-year biomedical nonprofit, was acquired by the Jackson Laboratory as part of a move to expand automation in life sciences research. The acquisition, ...

India Predicted XI For 1st ODI Against Australia: India take on Australia in the first ODI encounter at the Optus Stadium in Perth on Sunday. This will be the first match for the Indian cricket team ...

-Redefining Allergy Treatment with New Class of Trifunctional ECRIs designed to deliver powerful efficacy, rapid relief and complete control of allergic responses by targeting the effector cell - ...

Excellergy's trifunctional ECRIs remove IgE from mast cells and basophils, neutralize free IgE, and downregulate FceRI expression, offering improved allergy control. Pre-clinical data supports ECRIs' ...